Lamassu Bio Inc.
Durham, NC
- UEI
- UW1XNBTQ7EA5
- CAGE
- 9CDS8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 205 Regiment Way, Durham, NC 27705, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a novel small molecule MDM2 inhibitor for innovative sarcoma treatment | National Cancer Institute (NIH) | $2,027,310 |
Quick answers
Is Lamassu Bio Inc. registered in SAM.gov?
Yes. Lamassu Bio Inc.'s SAM.gov registration is active through April 3, 2027.
What is Lamassu Bio Inc.'s most recent federal award?
Lamassu Bio Inc.'s most recent federal grant award is Development of a novel small molecule MDM2 inhibitor for innovative sarcoma treatment (R44CA281622), from National Cancer Institute (NIH), on August 7, 2023.
On GovTribe
See Lamassu Bio Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors